Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sanya, Arshad"'
Autor:
Tomasz W. Kaminski, Eun-Mi Ju, Shweta Gudapati, Ravi Vats, Sanya Arshad, Rikesh K. Dubey, Omika Katoch, Egemen Tutuncuoglu, Jonathan Frank, Tomasz Brzoska, Donna B. Stolz, Simon C. Watkins, Stephen Y. Chan, Margaret V. Ragni, Enrico M. Novelli, Prithu Sundd, Tirthadipa Pradhan-Sundd
Publikováno v:
Blood Advances. 6:3729-3734
Hemophilia A is an inherited bleeding disorder caused by defective or deficient coagulation factor VIII (FVIII) activity. Until recently, the only treatment for prevention of bleeding involved IV administration of FVIII. Gene therapy with adeno-assoc
Autor:
Jeffrey W. Clark, Lauren Matlack, Sanya Arshad, Ryan B. Corcoran, Aparna Raj Parikh, Benjamin D. Greenbaum, Colin D. Weekes, Michael J. Raabe, Lorraine C. Drapek, Jon Dubois, Theodore S. Hong, David P. Ryan, David T. Ting, Lipika Goyal, Bronwen Foreman, Bruce J. Giantonio, Leilana Ly, Hannah Thel, Arnav Mehta, Lawrence S. Blaszkowsky, Nir Hacohen, Andrew X. Zhu, Jennifer Y. Wo, David Hoyos, Ryan D. Nipp, Emily E. Van Seventer, Jill N. Allen, Annamaria Szabolcs, Jessica A. Meurer, David J. Lieb, Beow Y. Yeap
Publikováno v:
Nature Cancer. 2:1124-1135
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable (MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains challenging. We conducted a single-arm, non-randomized, phase II trial (NCT03104
Autor:
Paul Zdinak, Stephanie Grebinoski, Jessica Torrey, Eduardo Zarate-Martinez, Louise Hicks, Rashi Ranjan, Nishtha Trivedi, Sanya Arshad, Mark Anderson, Dario AA Vignali, Alok V. Joglekar
CD4+ T cells recognize peptide antigens presented on class II Major Histocompatibility Complex (MHC-II) molecules to carry out their function. The remarkable diversity of T cell receptor (TCR) sequences and lack of antigen discovery approaches for MH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d019acb14b7542891872b9bc999dfbc5
https://doi.org/10.1101/2022.11.21.517373
https://doi.org/10.1101/2022.11.21.517373
Publikováno v:
Blood Coagulation & Fibrinolysis. 30:401-408
Inhibitor development in haemophilia A patients is a dreaded complication of factor VIII (FVIII) replacement therapy. With increasing use of FVIII replacement therapy, there is an imperative need for cost-effective and standardized screening. To eval
Publikováno v:
Transfusion and Apheresis Science. 61:103343
The acquisition of factor VIII inhibitors poses major management challenges for haemophilia A (HA) patients. Most (Factor VIII) inhibitors are immunoglobulin G4 (IgG4) and G1 (IgG1) subclasses, with IgG4 being the most prevalent. The Nijmegen Bethesd
Autor:
Beow Y. Yeap, Bronwen Foreman, David Hoyos, Nir Hacohen, Sanya Arshad, Jennifer Y. Wo, Lauren Matlack, Jon Dubois, Benjamin Greenbaum, Colin D. Weekes, David P. Ryan, David J. Lieb, Lawrence S. Blaszkowsky, Ryan D. Nipp, Arnav Mehta, Leilana Ly, Emily E. Van Seventer, Annamaria Szabolcs, Jill N. Allen, Jessica A. Meurer, Lorraine C. Drapek, Jeffrey W. Clark, Andrew X. Zhu, Ryan B. Corcoran, Lipika Goyal, Bruce J. Giantonio, Hannah Thel, Theodore S. Hong, David T. Ting, Aparna Raj Parikh
Immune checkpoint blockade has limited efficacy in microsatellite stable (MSS) colorectal (CRC) and pancreatic (PDAC) cancer. Preclinical models have demonstrated the use of radiation to activate the innate immune response and stimulate responsivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e56b0a1948d63053def5275a1df4e7f
https://doi.org/10.21203/rs.3.rs-58489/v1
https://doi.org/10.21203/rs.3.rs-58489/v1
Autor:
Aparna R, Parikh, Annamaria, Szabolcs, Jill N, Allen, Jeffrey W, Clark, Jennifer Y, Wo, Michael, Raabe, Hannah, Thel, David, Hoyos, Arnav, Mehta, Sanya, Arshad, David J, Lieb, Lorraine C, Drapek, Lawrence S, Blaszkowsky, Bruce J, Giantonio, Colin D, Weekes, Andrew X, Zhu, Lipika, Goyal, Ryan D, Nipp, Jon S, Dubois, Emily E, Van Seventer, Bronwen E, Foreman, Lauren E, Matlack, Leilana, Ly, Jessica A, Meurer, Nir, Hacohen, David P, Ryan, Beow Y, Yeap, Ryan B, Corcoran, Benjamin D, Greenbaum, David T, Ting, Theodore S, Hong
Publikováno v:
Nature cancer. 2(11)
Overcoming intrinsic resistance to immune checkpoint blockade for microsatellite stable (MSS) colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) remains challenging. We conducted a single-arm, non-randomized, phase II trial (NCT03104
Publikováno v:
Therapeutic Advances in Hematology. 9:213-226
Background: Development of inhibitors to transfused factor VIII in patients with hemophilia A continues to be a challenge for professionals involved in hemophilia care. The majority of patients in India receive ‘on-demand’ rather than prophylacti
Autor:
Swati Kumari, Sameer Gupta, Saumya Shukla, Nuzhat Husain, Sanya Arshad, Arun Chaturvedi, Azfar Neyaz, Nidhi Anand
Publikováno v:
Histopathology. 73(4)
AIMS Programmed death-ligand 1 (PD-L1), a potential target for immune checkpoint inhibitors in various solid neoplasms, has been studied in very few cases of Gall Bladder Carcinoma (GBC). The current study aimed to evaluate PD-L1 expression at primar
Supplemental material, Supplementary_Material for Clinicopathological parameters influencing inhibitor development in patients with hemophilia A receiving on-demand therapy by Sanya Arshad, Anshima Singh, Namrata Punit Awasthi, Swati Kumari and Nuzha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6841fb7760c86f5a0d6433ab3f6e62ad